“Pharma industry to grow to $130 billion by 2030”
The Hindu
There is strong push from government to create ecosystem for innovation in discovery of drugs and medical technology: S.V. Veeramani, vice-chairman, Pharmexcil
The Indian pharmaceutical industry is expected to grow at a compound annual rate (CAGR) of 12% and reach $130 billion by 2030, industry executives said at an industry event.
“There is a strong push from the government towards creating an ecosystem for innovation so that India can become a leader in discovery of drugs and medical technology,” said S.V. Veeramani, vice-chairman, Pharmexcil.
“Currently, the Indian pharmaceutical market is valued at around $50 billion, out of which almost $25 billion constitutes the export market. The domestic market will touch $130 billion by 2030 out of which over 60% will only be exports,’ he added.
Industry executives said the government should set up a separate Ministry for the pharma sector to encourage domestic producers and help bring down Chinese imports.
They also mulled the idea of having a single industry organisation to put across the grievances of the pharma industry before the government, to help expand it to its true potential.
They were speaking at the 15th edition of CPHI & PMEC India.
Vivek Singhal, director general of The Organisation of Pharmaceutical Producers of India said: “The industry needs to collaborate and co-work and unite for a collective voice on IPR related issues.”

When Union Minister for Road Transport and Highways, Nitin Gadkari, recently spoke about the transformative potential of Vehicle-to-Vehicle (V2V), a technology for autonomous driving in India, he framed it as a critical lever for safer roads, smarter traffic management and future-ready mobility. That vision is already finding concrete expression inside Samsung Electronics-owned HARMAN Automotive’s India operations, which are emerging as a global hub for software-defined and connected vehicle technologies, says Krishna Kumar, Managing Director and Automotive Head, HARMAN India.

ICICI Bank Ltd., the second largest private sector bank, for the third quarter ended 31 December 2025 reported 4% drop in net profit to ₹11,318 crore as compared to ₹ 11,792 crore in the year ago period on account of making additional standard asset provision of ₹1,283 crore during the quarter as per direction of the Reserve Bank of India (RBI).











